Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
The Biochemical Journal
|
March 19, 2013
A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation
Carolyn Bentley, Stefanie S Jurinka, Noelyn M Kljavin, et al.
Nature
|
April 17, 2015
A resource for cell line authentication, annotation and quality control
Mamie Yu, Suresh K Selvaraj, May M Y Liang-Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2014
High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing
Richard Bourgon, Shan Lu, Yibing Yan, et al.
Blood Advances
|
January 4, 2018
Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets
Christopher R Bolen, Ronald McCord, Sarah Huet, et al.
Neuro-Oncology
|
September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma
Radia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Plos One
|
December 31, 2021
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B
Anneleen Daemen, Akshata R Udyavar, Thomas Sandmann, et al.
The Journal of Molecular Diagnostics : JMD
|
September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing
Yinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
The Journal of Biological Chemistry
|
September 19, 2003
Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5
Anthony N Hodder, Damien R Drew, V Chandana Epa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors
David S Shames, Kristi Elkins, Kimberly Walter, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
The Biochemical Journal
|
March 19, 2013
A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation
Carolyn Bentley, Stefanie S Jurinka, Noelyn M Kljavin, et al.
Nature
|
April 17, 2015
A resource for cell line authentication, annotation and quality control
Mamie Yu, Suresh K Selvaraj, May M Y Liang-Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2014
High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing
Richard Bourgon, Shan Lu, Yibing Yan, et al.
Blood Advances
|
January 4, 2018
Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets
Christopher R Bolen, Ronald McCord, Sarah Huet, et al.
Neuro-Oncology
|
September 8, 2020
Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma
Radia M Johnson, Heidi S Phillips, Carlos Bais, et al.
Plos One
|
December 31, 2021
Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B
Anneleen Daemen, Akshata R Udyavar, Thomas Sandmann, et al.
The Journal of Molecular Diagnostics : JMD
|
September 5, 2017
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing
Yinghui Guan, Oleg Mayba, Thomas Sandmann, et al.
The Journal of Biological Chemistry
|
September 19, 2003
Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5
Anthony N Hodder, Damien R Drew, V Chandana Epa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors
David S Shames, Kristi Elkins, Kimberly Walter, et al.
Cancer Research
|
April 24, 2014
Comparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genes
Genee Y Lee, Peter M Haverty, Li Li, et al.
Page
of 6